118 related articles for article (PubMed ID: 11814804)
21. Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives.
Ren Y; Kinghorn AD
Bioorg Med Chem; 2021 Feb; 32():116012. PubMed ID: 33454654
[TBL] [Abstract][Full Text] [Related]
22. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
[TBL] [Abstract][Full Text] [Related]
23. Effects of serine/threonine protein phosphatase inhibitors on morphine-induced antinociception in the tail flick test in mice.
Moncada A; Cendán CM; Baeyens JM; Del Pozo E
Eur J Pharmacol; 2003 Mar; 465(1-2):53-60. PubMed ID: 12650833
[TBL] [Abstract][Full Text] [Related]
24. Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidin.
To KK; Wang X; Yu CW; Ho YP; Au-Yeung SC
Bioorg Med Chem; 2004 Sep; 12(17):4565-73. PubMed ID: 15358284
[TBL] [Abstract][Full Text] [Related]
25. The effects of cantharidin analogues on xanthine oxidase.
Tsauer W; Lin JG; Lin PY; Hsu FL; Chiang HC
Anticancer Res; 1997; 17(3C):2095-8. PubMed ID: 9216670
[TBL] [Abstract][Full Text] [Related]
26. Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): implications for the binding mode.
Baba Y; Hirukawa N; Sodeoka M
Bioorg Med Chem; 2005 Sep; 13(17):5164-70. PubMed ID: 15951185
[TBL] [Abstract][Full Text] [Related]
27. Contractility and inhibition of protein phosphatases by cantharidin.
Knapp J; Bokník P; Huke S; Gombosová I; Linck B; Lüss H; Müller FU; Müller T; Nacke P; Schmitz W; Vahlensieck U; Neumann J
Gen Pharmacol; 1998 Nov; 31(5):729-33. PubMed ID: 9809469
[TBL] [Abstract][Full Text] [Related]
28. The design, synthesis, and biological evaluation of analogues of the serine-threonine protein phosphatase 1 and 2A selective inhibitor microcystin LA: rational modifications imparting PP1 selectivity.
Aggen JB; Humphrey JM; Gauss CM; Huang HB; Nairn AC; Chamberlin AR
Bioorg Med Chem; 1999 Mar; 7(3):543-64. PubMed ID: 10220039
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic effects of cantharidin analogues without bridging ether oxygen on human hepatocellular carcinoma cells.
Yeh CB; Su CJ; Hwang JM; Chou MC
Eur J Med Chem; 2010 Sep; 45(9):3981-5. PubMed ID: 20691337
[TBL] [Abstract][Full Text] [Related]
30. Interactions of cantharidin-like inhibitors with human protein phosphatase-5 in a Mg
Assis LC; de Castro AA; Prandi IG; Mancini DT; de Giacoppo JOS; Savedra RML; de Assis TM; Carregal JB; da Cunha EFF; Ramalho TC
J Mol Model; 2018 Oct; 24(10):303. PubMed ID: 30280322
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological activity of Delta-5,6-norcantharimides: importance of the 5,6-bridge.
Thaqi A; Scott JL; Gilbert J; Sakoff JA; McCluskey A
Eur J Med Chem; 2010 May; 45(5):1717-23. PubMed ID: 20153915
[TBL] [Abstract][Full Text] [Related]
32. Effects of phosphoprotein phosphatase inhibitors (phenylarsine oxide and cantharidin) on Tetrahymena.
Kovács P; Pintér M
Cell Biochem Funct; 2001 Sep; 19(3):197-205. PubMed ID: 11494309
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of norcantharidin analogues: towards PP1 selectivity.
Stewart SG; Hill TA; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
Bioorg Med Chem; 2007 Dec; 15(23):7301-10. PubMed ID: 17870547
[TBL] [Abstract][Full Text] [Related]
34. Development and validation of a robust and sensitive assay for the discovery of selective inhibitors for serine/threonine protein phosphatases PP1α (PPP1C) and PP5 (PPP5C).
Swingle MR; Honkanen RE
Assay Drug Dev Technol; 2014 Oct; 12(8):481-96. PubMed ID: 25383722
[TBL] [Abstract][Full Text] [Related]
35. Radiosensitization of tumour cells by cantharidin and some analogues.
Price WA; Stobbe CC; Park SJ; Chapman JD
Int J Radiat Biol; 2004 Apr; 80(4):269-79. PubMed ID: 15204704
[TBL] [Abstract][Full Text] [Related]
36. Protein phosphatase 2A is involved in hyphal growth of Neurospora crassa.
Yatzkan E; Szöor B; Fehér Z; Dombrádi V; Yarden O
Mol Gen Genet; 1998 Sep; 259(5):523-31. PubMed ID: 9790584
[TBL] [Abstract][Full Text] [Related]
37. Cantharidin enhances norepinephrine-induced vasoconstriction in an endothelium-dependent fashion.
Knapp J; Bokník P; Linck B; Lüss H; Müller FU; Petertönjes L; Schmitz W; Neumann J
J Pharmacol Exp Ther; 2000 Aug; 294(2):620-6. PubMed ID: 10900240
[TBL] [Abstract][Full Text] [Related]
38. Endothall thioanhydride inhibits protein phosphatases-1 and -2A in vivo.
Erdödi F; Tóth B; Hirano K; Hirano M; Hartshorne DJ; Gergely P
Am J Physiol; 1995 Nov; 269(5 Pt 1):C1176-84. PubMed ID: 7491907
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional responses to cantharidin, a protein phosphatase inhibitor, in Arabidopsis thaliana reveal the involvement of multiple signal transduction pathways.
Bajsa J; Pan Z; Duke SO
Physiol Plant; 2011 Oct; 143(2):188-205. PubMed ID: 21668865
[TBL] [Abstract][Full Text] [Related]
40. Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse.
Swingle M; Ni L; Honkanen RE
Methods Mol Biol; 2007; 365():23-38. PubMed ID: 17200551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
